Deciphera Pharmaceuticals, Inc.

NasdaqGS:DCPH 주식 보고서

시가총액: US$2.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Deciphera Pharmaceuticals 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

NasdaqGS:DCPH 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
16 Feb 24SellUS$35,405Jama PitmanIndividual2,267US$15.62
16 Feb 24SellUS$35,405Daniel MartinIndividual2,267US$15.62
16 Feb 24SellUS$47,009Thomas KellyIndividual3,010US$15.62
16 Feb 24SellUS$40,840Matthew ShermanIndividual2,615US$15.62
16 Jan 24SellUS$23,499Daniel MartinIndividual1,624US$14.47
16 Jan 24SellUS$35,234Thomas KellyIndividual2,435US$14.47
16 Jan 24SellUS$23,499Jama PitmanIndividual1,624US$14.47
16 Jan 24SellUS$35,234Matthew ShermanIndividual2,435US$14.47
13 Dec 23SellUS$42,905Matthew ShermanIndividual2,792US$15.37
13 Dec 23SellUS$26,539Daniel MartinIndividual1,727US$15.37
13 Dec 23SellUS$42,905Thomas KellyIndividual2,792US$15.37
13 Dec 23SellUS$25,540Jama PitmanIndividual1,662US$15.37
13 Dec 23SellUS$471,217Steven HoerterIndividual30,664US$15.37
30 Nov 23SellUS$223,755Daniel MartinIndividual17,801US$12.57
30 Oct 23SellUS$259,256Steven HoerterIndividual21,573US$12.02
30 Oct 23SellUS$28,362Matthew ShermanIndividual2,360US$12.02
30 Oct 23SellUS$27,833Thomas KellyIndividual2,316US$12.02
30 Oct 23SellUS$16,909Daniel MartinIndividual1,407US$12.02
30 Oct 23SellUS$16,909Jama PitmanIndividual1,407US$12.02
02 Oct 23SellUS$37,305Matthew ShermanIndividual2,942US$12.68

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.


소유권 분석

DCPH 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업1,5970.00185%
개인 내부자615,1930.711%
일반 대중1,905,9232.2%
헤지 펀드16,323,91318.9%
VC/PE 기업23,107,84426.7%
교육기관44,521,50251.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 10.1% 만큼 증가했습니다.


최대 주주

상위 25 주주가 회사의 82.75%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
26.7%
Brightstar Associates, LLC
23,107,844US$591.3m0.21%데이터 없음
6.93%
BlackRock, Inc.
5,994,276US$153.4m0.3%데이터 없음
6.82%
Armistice Capital LLC
5,900,000US$151.0m13.5%4.18%
6.12%
Redmile Group, LLC
5,296,643US$135.5m10.3%5.46%
5.93%
Deerfield Management Company, L.P. Series C
5,127,270US$131.2m-11.4%2.38%
5.28%
The Vanguard Group, Inc.
4,565,044US$116.8m3.71%데이터 없음
3.58%
State Street Global Advisors, Inc.
3,098,806US$79.3m25.4%데이터 없음
2.16%
Emerald Advisers, LLC
1,869,273US$47.8m56.1%1.08%
1.86%
Dimensional Fund Advisors LP
1,606,132US$41.1m2.85%0.01%
1.73%
Polar Capital Holdings Plc
1,500,000US$38.4m-18.9%0.15%
1.69%
Goldman Sachs Group, Investment Banking and Securities Investments
1,463,417US$37.4m-19.5%0.02%
1.68%
Frazier Life Sciences Management, LP
1,455,837US$37.3m42.5%1.79%
1.65%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,422,770US$36.4m0.89%0.01%
1.53%
Morgan Stanley, Investment Banking and Brokerage Investments
1,321,377US$33.8m-37%데이터 없음
1.45%
Geode Capital Management, LLC
1,254,317US$32.1m2.7%데이터 없음
0.95%
Jefferies Financial Group Inc.,Asset Management Arm
822,515US$21.0m-10.4%0.51%
0.94%
Assenagon Asset Management S.A.
809,923US$20.7m0%0.04%
0.92%
Millennium Management LLC
797,100US$20.4m22.2%0.02%
0.84%
Parkman Healthcare Partners LLC
729,230US$18.7m30%2.44%
0.7%
Braidwell LP
609,643US$15.6m-47.9%0.96%
0.69%
Tang Capital Management, LLC
600,000US$15.4m0%1.86%
0.67%
New Leaf Venture Partners, LLC
576,975US$14.8m0%15.11%
0.65%
UBS Asset Management AG
564,978US$14.5m7.34%데이터 없음
0.61%
Charles Schwab Investment Management, Inc.
531,475US$13.6m3.14%데이터 없음
0.61%
Renaissance Technologies LLC
530,200US$13.6m21.2%0.02%